DESCRIPTION OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013 Item
Concentration of Risk
Accounts receivable	$ 450
VIBATIV
Concentration of Risk
Number of suppliers providing fill-finish services related to the manufacturing of the product	1
Accounts receivable | Distributor
Concentration of Risk
Accounts receivable	450
Percentage of Total Accounts Receivable Balance	100.00%
Accounts receivable | Distributor | AmerisourceBergen Drug Corporation
Concentration of Risk
Accounts receivable	285
Percentage of Total Accounts Receivable Balance	63.00%
Accounts receivable | Distributor | Cardinal Health, Inc.
Concentration of Risk
Accounts receivable	103
Percentage of Total Accounts Receivable Balance	23.00%
Accounts receivable | Distributor | McKesson Corporation
Concentration of Risk
Accounts receivable	59
Percentage of Total Accounts Receivable Balance	13.00%
Accounts receivable | Distributor | Other
Concentration of Risk
Accounts receivable	$ 3
Percentage of Total Accounts Receivable Balance	1.00%